A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer

Villaruz, LC; Cobo, M; Syrigos, K; Mavroudis, D; Zhang, W; Kim, JS; Socinski, MA

Villaruz, LC (reprint author), UPMC Hillman Canc Ctr, 5150 Ctr Ave, Pittsburgh, PA 15232 USA.

LUNG CANCER, 2019; 136 (): 52

Abstract

Objectives: Necitumumab is a second-generation, recombinant, human IgG1-type monoclonal antibody directed against EGFR approved for adult patients wit......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索